Diarrhea Predominant Irritable Bowel Syndrome in Females

NCT00461526 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: crofelemer

Sponsor

Bausch Health Americas, Inc.